Valorisation of the Invasive Macroalgae Undaria pinnatifida (Harvey) Suringar for the Green Synthesis of Gold and Silver Nanoparticles with Antimicrobial and Antioxidant Potential.
Noelia González-BallesterosMário FernandesRaul MachadoPaula SampaioAndreia Castro GomesAntonella CavazzaFranca BigiMaria Carmen Rodríguez-ArgüellesPublished in: Marine drugs (2023)
Bacterial and fungal infections are a challenging global problem due to the reported increasing resistance of pathogenic microorganisms to conventional antimicrobials. Nanomaterials are a promising strategy to fight infections caused by multidrug-resistant microbes. In this work, gold (Au@UP) and silver (Ag@UP) nanoparticles were produced for the first time by green synthesis using an aqueous extract of the invasive macroalgae Undaria pinnatifida (UP). The nanoparticles were characterized by a wide range of physicochemical techniques. Au@UP and Ag@UP demonstrated to be spherical and crystalline with an average size of 6.8 ± 1.0 nm and 14.1 ± 2.8 nm, respectively. Carbohydrates and proteins of the UP extract may participate in the synthesis and capping of the nanoparticles. The UP extract, Ag@UP, and Au@UP were assessed for their antimicrobial activity against Escherichia coli , Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans , and Candida auris. Ag@UP showed the highest antimicrobial activity with very low MIC and MBC values for all the tested bacteria, and Au@UP demonstrated to be very effective against biofilm-producing bacteria. The antifungal properties of both Ag@UP and Au@UP were remarkable, inhibiting hyphae formation. This study points towards a very promising biomedical exploitation of this invasive brown algae.
Keyphrases
- candida albicans
- biofilm formation
- visible light
- silver nanoparticles
- sensitive detection
- quantum dots
- staphylococcus aureus
- pseudomonas aeruginosa
- oxidative stress
- reduced graphene oxide
- escherichia coli
- multidrug resistant
- highly efficient
- anti inflammatory
- gold nanoparticles
- photodynamic therapy
- acinetobacter baumannii
- drug resistant
- signaling pathway
- klebsiella pneumoniae
- risk assessment
- room temperature
- ionic liquid
- human health